Nasdaq
BLTE
Belite Bio, Inc
- Health Care
- Listed 2022
- 1 day
- +1.4%
- 1 month
- +1.9%
- 1 year
- +136%
$160.67 · Mkt cap $6.32B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Belite Bio, Inc
$160.67 · Mkt cap $6.32B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Belite Bio, Inc trades under the ticker BLTE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2022. Its market capitalisation is $6.32B. The last closing price was $160.67, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +136%, and +1.9% over the past month. Returns are price returns and exclude dividends.
This page exists because BLTE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.